Kayyem Jon Faiz

SEC Form 4 insider
Inhibrx Biosciences, Inc. ($INBX)
1 thesis · first seen Sep 17, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$INBXSEC Form 4bullish
Kayyem Jon Faiz · Inhibrx Biosciences, Inc. · 46d agono track record yet
Long 5,000 shares of INBX
Bought 5,000 @ $100.00 avg · $500,000 · 2026-09-16

Form 4: Kayyem Jon Faiz bought INBX

Kayyem Jon Faiz (Director at Inhibrx Biosciences, Inc.) reported an open-market purchase of 5,000 shares of INBX at an average $100.00, roughly $500,000, in a Form 4 filed 2026-09-17.

At post $104.73Now $72.16-31.1% since postedas of Nov 2, 4:15 PM ET
1d+4.4%
3d+4.4%
1w-4.1%
1m-14.2%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.